• IEM 1460: Optimizing AMPA Receptor Blocker Assays in Neurosc

  2026-05-11

  IEM 1460 empowers precise, selective AMPA receptor inhibition for robust excitotoxicity, neuroprotection, and synaptic modulation assays. This guide offers stepwise workflow enhancements, troubleshooting strategies, and practical insights from cutting-edge research to help neuroscientists maximize reproducibility and translational impact.

• PDK4-IN-1 Hydrochloride: Optimizing Metabolic Research Workf

  2026-05-11

  PDK4-IN-1 hydrochloride stands out for its nanomolar selectivity and versatility in both in vitro and in vivo metabolic studies. This article distills experimental best practices, highlights troubleshooting strategies, and uniquely bridges literature-backed protocols with practical workflow enhancements for researchers targeting mitochondrial energy metabolism.

• Dual Glutamate Receptor Antagonism for Neuroprotection in So

  2026-05-10

  The reference study demonstrates that targeting both AMPA and NMDA receptors with IEM-1925 offers robust antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. These findings establish a strong rationale for dual glutamate receptor blockade as a promising strategy in organophosphorus nerve agent neurotoxicity, informing translational assay design and neuroprotection research.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Applicat

  2026-05-09

  FITC-Concanavalin A (ConA) Conjugate provides a targeted, fluorescence-based method for detecting α-D-glucose and α-D-mannose residues on cell surfaces. It is optimized for immunofluorescence staining, flow cytometry, and glycobiology workflows, but should not be used beyond its defined stability window or for non-carbohydrate-binding assays.

• KR-12 Peptide–Cu(II) Binding: Structural Insights via Theory

  2026-05-09

  This study combines advanced computational modeling with experimental titration to unravel how KR-12, a minimal antimicrobial peptide from human cathelicidin LL-37, binds Cu(II) ions. The findings clarify the specific peptide fragments and amino acids coordinating the metal, informing rational design of peptide-based antimicrobials and bioconjugates.

• Liproxstatin-1 HCl: Optimizing Ferroptosis Assays & Injury M

  2026-05-08

  Liproxstatin-1 HCl empowers researchers to dissect ferroptosis with nanomolar specificity, bridging breakthrough mechanistic insight with robust workflows in acute renal failure and hepatic ischemia/reperfusion injury models. This guide details protocol parameters, troubleshooting strategies, and the latest comparative innovations to streamline application in both cellular and in vivo settings.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow & I

  2026-05-07

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers researchers with tunable, high-yield fluorescent RNA probe synthesis for demanding applications like in situ hybridization and Northern blotting. Its flexible Cy5-UTP incorporation and robust troubleshooting streamline sensitive detection and workflow customization.

• 2-Deoxy-D-glucose: Optimizing Glycolysis Inhibition Protocol

  2026-05-07

  2-Deoxy-D-glucose (2-DG) stands out as a precision glycolysis inhibitor with proven cytotoxicity in KIT-positive GISTs and synergy in chemotherapy. This guide translates the latest immunometabolic research into actionable workflows, troubleshooting strategies, and advanced use-cases for cancer and virology labs.

• Drosophila Keap1 Forms Nuclear Condensates During Oxidative

  2026-05-06

  This study uncovers that Drosophila Keap1 assembles nuclear biomolecular condensates in response to oxidative stress, a process dependent on both N- and C-terminal domains and regulated by intrinsically disordered regions. These findings reveal a novel nuclear mechanism for Keap1 in gene regulation and highlight new avenues for dissecting chromatin-related stress responses.

• CDC42 Regulates Intestinal Stem Cell Fate via YAP-mTOR Signa

  2026-05-06

  This article examines how CDC42-driven epithelial polarity orchestrates the fate balance between intestinal stem cells and transit amplifying cells via YAP-EGF-mTOR signaling, independent of canonical Wnt pathways. The findings clarify a critical mechanism maintaining gut epithelial homeostasis and offer a foundation for advanced gastrointestinal stem cell and polarity research.

• HGFA Identified as a Serum Biomarker for Pulmonary Hypertens

  2026-05-05

  Zhang et al. (2024) employed quantitative serum proteomics and animal validation to identify hepatocyte growth factor activator (HGFA) as a strong candidate biomarker for pulmonary arterial hypertension (PAH). Their findings suggest HGFA's potential for noninvasive PAH detection and highlight a robust multi-method approach for biomarker discovery in vascular disease.

• Bufuralol Hydrochloride in Advanced Cardiovascular Pharmacol

  2026-05-05

  Bufuralol hydrochloride enables high-fidelity β-adrenergic modulation studies in both next-generation human iPSC-derived organoids and classic tachycardia models. This article provides detailed, evidence-driven workflows and troubleshooting guidance to empower cardiovascular pharmacology research with reproducible, translatable insights.

• ECL Chemiluminescent Substrate Detection Kit: Precision in P

  2026-05-04

  The ECL Chemiluminescent Substrate Detection Kit from APExBIO empowers scientists to achieve ultrasensitive Western blot and immunoassay results, particularly for low-abundance proteins. Its robust design ensures reliable HRP-based chemiluminescent detection, with workflow flexibility that directly supports emerging research in cancer biology and immunology.

• Chenodeoxycholic Acid in FXR Signaling & CI-AKI Protection

  2026-05-04

  Chenodeoxycholic Acid (CDCA) is redefining metabolic and renal research as a precise FXR agonist, enabling robust modeling of bile acid and nuclear receptor signaling pathways. Its documented role in upregulating KLF11 and suppressing JAK2/STAT3 makes CDCA an indispensable tool for studies in cholesterol metabolism and acute kidney injury.

• Liproxstatin-1 HCl: Precision Ferroptosis Inhibition for Tra

  2026-05-03

  Liproxstatin-1 HCl empowers researchers to dissect ferroptosis with nanomolar precision, providing robust protection against lipid peroxidation in acute renal failure and hepatic ischemia/reperfusion injury models. Leverage the latest mechanistic insights and protocol refinements to enhance data reliability and translational relevance.

16465 records 1/1098 page Next 12345 下5页 Last page